TABLE 2.
n | Baseline A1C, % | 6-Month A1C, % | Change in A1C, %* | F | P | |
---|---|---|---|---|---|---|
CC-DDR total group | 12 | 8.7 (2.1) | 8.1 (0.9) | –0.6 (2.1) | ||
Trust subgroup | 7 | 9.1 (2.7) | 7.7 (0.8) | –1.4 (2.5) | ||
Mistrust subgroup | 5 | 8.2 (1.1) | 8.5 (0.9) | 0.36 (0.7) | ||
EUC, total group | 17 | 8.5 (0.9) | 8.7 (1.6) | 0.2 (1.1) | ||
Trust subgroup | 10 | 8.5 (1.0) | 8.4 (1.8) | –0.1 (1.1) | ||
Mistrust subgroup | 7 | 8.4 (0.8) | 9.1 (1.2) | 0.7 (1.1) | ||
Main effect of treatment group | 1.7 | 0.202 | ||||
Main effect of trust group | 4.5 | 0.044 | ||||
Treatment by trust interaction | 0.6 | 0.441 |
Data are expressed as mean (SD).
6-month minus baseline A1C; negative signs indicate improved glycemic control.